Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failure

BackgroundPatients with Fontan physiology frequently develop Fontan circulatory failure (FCF), but there are no evidence-based pharmacological treatment options.ObjectivesThis study evaluated the safety and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in FCF.MethodsA real-world, mu...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ralph M. L. Neijenhuis, Ari M. Cedars, Ali Zaidi, Guillermo Torres-Viera, Renata Mazurek, Niki L. Walker, Filip Zemrak, Simon T. MacDonald, Amanda Hunter, Philippine Kiès, Lena Bosch, Lorna Swan, Heleen B. van der Zwaan, J. Wouter Jukema, Monique R. M. Jongbloed, Gruschen R. Veldtman, Anastasia D. Egorova
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-05-01
Edice:	Frontiers in Cardiovascular Medicine
Témata:	adult congenital heart disease (ACHD) FCF heart failure SGLT2I single ventricle univentricular
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fcvm.2026.1771868/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!